REVBW Revelation Biosciences, Inc. - Warrant
NASDAQ · Visualizza su SEC EDGAR ↗ chiudi Set 30, 2026 10-K/10-Q Ago 6, 2026
$0,01
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$0,00minimo 52 sett.
$0,01massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$27.0K
P/E
-0.0
EPS
$-23.95
i tuoi badge
Intervallo 52 sett.
$0–$0
Rating Analisti
·
Prezzo Obiettivo
·
P/E
-0.0
ROE
-140.5%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
REVBW Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$0.01
Capitalizzazione di Mercato (MRQ)
$27.0K
P/E
-0.0
EPS
$-23.95
ROE
-140.5%
Intervallo 52 sett.
$0–$0
REVBW Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
EPS$-23.952021-12-31 → 2025-12-31
Flusso di cassa libero·2024-12-31 → 2024-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | REVBW | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -0.0 | · | · | · | |
| P/B (MRQ) | 0.0 | · | · | · | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -0.0 | · | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 0.0 | · | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | REVBW | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -97.9%media 5 anni ≈-137.0% | ≈-137.0% | · | · | |
| ROE | -140.5%media 5 anni ≈-276.5% | ≈-276.5% | · | · |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | REVBW | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 6.2media 5 anni ≈2.5 | ≈2.5 | · | · | |
| Quick Ratio | 5.4media 5 anni ≈2.5 | ≈2.5 | · | · |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $4M | $4M | $4M | $5M | $7M | · | · | |
| SG&A Expense | $5M | $4M | $5M | $5M | $5M | $145.5K | · | |
| Operating Expenses | $9M | $8M | $9M | $11M | $12M | $145.5K | · | |
| Operating Income | $-9M | $-8M | $-9M | $-11M | $-12M | · | · | |
| Interest Expense | · | · | · | · | $41.8K | · | · | |
| Interest Income | · | · | · | · | $222 | $9.3K | · | |
| Other Non-op | $155.0K | $-7M | $207.5K | $35.0K | $-36.4K | $-1M | · | |
| Pretax Income | · | · | · | · | · | $-2M | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-9M | $-15M | $-120.3K | $-11M | $-12M | $-2M | $-3.6K | |
| EPS (Basic) | $-23.95 | $-1052.16 | $-8.44 | $-149.20 | $-42.50 | $-0.68 | · | |
| EPS (Diluted) | $-23.95 | $-1052.16 | $-8.44 | $-149.20 | $-42.50 | · | · | |
| Shares (Basic) | 620,785 | 14,293 | 14,246 | 72,585 | 282,035 | 2,409,951 | · | |
| Shares (Diluted) | 620,785 | 14,293 | 14,246 | 72,585 | 282,035 | · | · | |
| EBITDA | $-9M | $-8M | $-9M | $-11M | · | · | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $6M | $12M | $5M | $1M | $11.7K | · | |
| Short-term Investments | · | · | · | · | · | $525.3K | · | |
| Prepaid Expense | $111.3K | $66.7K | $84.7K | $73.1K | $637.3K | $114.3K | · | |
| Current Assets | $11M | $7M | $12M | $5M | $2M | $651.3K | $22.7K | |
| PP&E (Net) | $18.1K | $56.3K | $65.1K | $90.1K | $115.2K | · | · | |
| PP&E (Gross) | $117.1K | $151.1K | $132.0K | $132.0K | $132.0K | · | · | |
| Accum. Depreciation | $99.0K | $94.8K | $66.9K | $41.8K | $16.8K | · | · | |
| Other Non-current Assets | $30.9K | $0 | · | · | · | · | · | |
| Total Assets | $12M | $7M | $12M | $6M | $2M | $74M | $22.7K | |
| Accounts Payable | $577.5K | $783.6K | $1M | $554.2K | $596.3K | $33.8K | · | |
| Accrued Liabilities | $1M | $1M | $1M | $985.5K | $2M | $33.8K | $16.3K | |
| Current Liabilities | $2M | $2M | $6M | $4M | $2M | $3M | $26.3K | |
| Capital Leases | $723.8K | $0 | · | · | · | · | · | |
| Total Liabilities | $3M | $2M | $6M | $4M | $2M | $6M | $26.3K | |
| Common Stock | $1.6K | $44 | $16 | $77 | $282 | $1.8K | · | |
| Paid-in Capital | $58M | $45M | $32M | $26M | $14M | · | · | |
| Retained Earnings | $-49M | $-41M | $-25M | $-25M | $-15M | $-6M | $-3.6K | |
| Stockholders' Equity | $9M | $5M | $7M | $1M | $-99.5K | $3M | $-3.6K | |
| Liabilities + Equity | $12M | $7M | $12M | $6M | $2M | $74M | $22.7K | |
| Shares Outstanding | 1,583,969 | 43,526 | 16,484 | 77,375 | 282,039 | 1,819,538 | 1,819,538 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $595.4K | $168.8K | $155.7K | $301.1K | $470.9K | · | · | |
| Operating Cash Flow | $-8M | $-18M | $-7M | $-11M | $-11M | $-216.7K | · | |
| CapEx | · | $19.2K | · | · | $132.0K | · | · | |
| Investing Cash Flow | · | $-19.2K | · | · | $-132.0K | $-74M | · | |
| Stock Issued | · | $13M | · | · | $600.0K | $6M | · | |
| Stock Repurchased | · | · | · | · | $36M | · | · | |
| Net Stock Activity | · | · | · | · | $-36M | · | · | |
| Financing Cash Flow | $12M | $13M | $14M | $15M | $8M | $74M | · | |
| Net Change in Cash | · | · | · | · | · | $11.7K | · | |
| Free Cash Flow | · | $-18M | · | · | · | · | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -97.9% | -159.7% | · | -287.0% | -3.5% | -4.4% | · | |
| ROE | -140.5% | -407.4% | · | -660.3% | 102.2% | 57.4% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 3.4 | · | 1.2 | 0.0 | 0.2 | · | |
| Quick Ratio | 5.4 | 3.4 | · | 1.2 | 0.0 | 0.2 | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.59 | $9.02 | · | $1.54 | $-4.30 | $-3.13 | · | |
| Cash Flow / Share | $-13.32 | $-106.82 | $-31.87 | $-20.81 | · | · | · | |
| Cash / Share | $6.76 | $12.44 | · | $7.69 | $0.04 | $0.01 | · | |
| EPS (TTM) | $-23.95 | $-1052.16 | $-8.44 | $-149.20 | $-42.50 | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-9M | $-15M | $-120.3K | $-11M | $-12M | $-2M | · | |
| Market Cap | $17.3K | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | · | · | · | · | · | · | |
| P / Cash Flow | -0.0 | · | · | · | · | · | · | |
| Earnings Yield | -219724.8% | · | · | · | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $964.2K | $922.9K | $1M | $858.8K | $605.5K | $831.0K | $1M | $717.6K | $1M | $2M | $909.3K | $525.3K | $340.0K | $381.6K | $975.6K | |
| SG&A Expense | $2M | $2M | $1M | $1M | $1M | $1M | $965.7K | $1M | $1M | $1M | $1M | $1M | $1M | $878.4K | $817.9K | $884.8K | |
| Operating Expenses | $4M | $3M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $1M | $1M | $2M | |
| Operating Income | $-4M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-2M | $-3M | $-2M | $-2M | $-1M | $-1M | $-2M | |
| Other Non-op | $338.9K | $60.5K | $35.2K | $16.8K | $42.5K | $25.6K | $-450.9K | $-6M | $-847.7K | $54.8K | $57.0K | $61.6K | $34.1K | $10.7K | $28.7K | $25.7K | |
| Income Tax | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-8M | $-3M | $-2M | $-3M | $-1M | $6M | $-1M | $-1M | $-2M | |
| EPS (Basic) | $-0.87 | $-13.06 | $-1.77 | $-28.04 | $-2.11 | $-726.37 | $-40.15 | $-246.27 | $-39.37 | $-38.19 | $-9.94 | $-5.83 | $45.52 | $-127.23 | $-1.91 | $-4.16 | |
| EPS (Diluted) | $-0.87 | $-13.06 | $-1.77 | $-28.04 | $-2.11 | $-726.37 | $-40.15 | $-246.27 | $-39.37 | $-29.74 | $-9.94 | $-5.83 | $37.07 | $-127.23 | $-1.91 | $-4.16 | |
| Shares (Basic) | 3,829,363 | · | 2,644,733 | 200,668 | 971,313 | · | 55,832 | 34,067 | 68,115 | · | 264,537 | 248,369 | 135,305 | · | 611,998 | 441,351 | |
| Shares (Diluted) | 3,829,363 | · | 2,644,733 | 200,668 | 971,313 | · | 55,832 | 34,067 | 68,115 | · | 264,537 | 248,369 | 166,144 | · | 611,998 | 441,351 | |
| EBITDA | $-4M | · | $-2M | $-2M | $-2M | · | $-2M | · | $-2M | · | $-3M | $-2M | $-2M | · | $-1M | $-2M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $11M | $13M | $5M | $4M | $6M | $7M | $12M | $15M | $12M | $14M | $16M | $18M | $5M | $6M | $3M | |
| Prepaid Expense | $201.7K | $111.3K | $123.9K | $186.0K | $223.3K | $66.7K | $117.8K | $125.7K | $71.9K | $84.7K | $152.6K | $250.0K | $332.4K | $73.1K | $309.6K | $575.5K | |
| Current Assets | $12M | $11M | $13M | $5M | $4M | $7M | $7M | $12M | $15M | $12M | $14M | $16M | $18M | $5M | $7M | $4M | |
| PP&E (Net) | $172.0K | $18.1K | $23.9K | $35.2K | $42.4K | $56.3K | $81.2K | $70.8K | $78.0K | $65.1K | $71.3K | $77.6K | $83.9K | $90.1K | $96.4K | $102.7K | |
| PP&E (Gross) | $286.5K | $117.1K | · | · | · | $151.1K | $168.8K | $151.1K | $151.1K | $132.0K | $132.0K | $132.0K | $132.0K | $132.0K | $132.0K | $132.0K | |
| Accum. Depreciation | $114.5K | $99.0K | · | · | · | $94.8K | $87.6K | $80.4K | $73.1K | $66.9K | $60.6K | $54.4K | $48.1K | $41.8K | $35.6K | $29.3K | |
| Other Non-current Assets | $30.9K | $30.9K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $12M | $12M | $13M | $5M | $4M | $7M | $7M | $12M | $15M | $12M | $14M | $16M | $18M | $6M | $7M | $4M | |
| Accounts Payable | $931.1K | $577.5K | $1M | $828.9K | $625.1K | $783.6K | $3M | $1M | $2M | $1M | $1M | $913.9K | $705.1K | $554.2K | $466.1K | $916.5K | |
| Accrued Liabilities | $759.9K | $1M | $819.4K | $739.6K | $463.6K | $1M | $934.4K | $8M | $620.3K | $1M | $1M | $496.9K | $973.9K | $985.5K | $996.4K | $2M | |
| Current Liabilities | $2M | $2M | $2M | $2M | $1M | $2M | $4M | $11M | $5M | $6M | $5M | $5M | $8M | $4M | $4M | $6M | |
| Capital Leases | $550.5K | $723.8K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $2M | $3M | $2M | $2M | $1M | $2M | $4M | $11M | $5M | $6M | $5M | $5M | $8M | $4M | $4M | $6M | |
| Common Stock | $3.9K | $1.6K | $3.6K | $1.5K | $964 | $44 | $4.3K | $1.6K | $1.6K | $16 | $6.3K | $6.3K | $4.7K | $77 | $23.5K | $15.1K | |
| Paid-in Capital | $66M | $58M | $58M | $49M | $45M | $45M | $41M | $38M | $38M | $32M | $32M | $32M | $29M | $26M | $26M | $21M | |
| Retained Earnings | $-56M | $-49M | $-47M | $-45M | $-43M | $-41M | $-39M | $-37M | $-28M | $-25M | $-23M | $-21M | $-19M | $-25M | $-24M | $-23M | |
| Stockholders' Equity | $10M | $9M | $11M | $4M | $3M | $5M | $3M | $1M | $9M | $7M | $9M | $11M | $10M | $1M | $2M | $-2M | |
| Liabilities + Equity | $12M | $12M | $13M | $5M | $4M | $7M | $7M | $12M | $15M | $12M | $14M | $16M | $18M | $6M | $7M | $4M | |
| Shares Outstanding | 3,908,420 | 1,583,969 | 3,585,972 | 1,534,637 | 963,796 | 43,526 | 4,292,455 | 1,643,395 | 1,632,935 | 16,484 | 6,297,303 | 6,297,303 | 4,729,839 | 77,375 | 23,536,070 | 15,082,771 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $401.4K | $370.2K | $874 | $873 | $223.5K | $72.6K | $32.1K | $32.1K | $32.1K | $32.1K | $32.1K | $59.4K | $32.1K | $32.4K | $40.7K | $90.2K | |
| Operating Cash Flow | $-3M | $-2M | $-2M | $-2M | $-3M | $-4M | $-9M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-947.5K | $-2M | $-4M | |
| CapEx | $39.6K | · | · | · | · | $-17.7K | $17.7K | $0 | $19.2K | · | $0 | $0 | $0 | · | · | · | |
| Investing Cash Flow | $-39.6K | · | · | · | · | $17.7K | $-17.7K | $0 | $-19.2K | · | $0 | $0 | $0 | · | · | · | |
| Financing Cash Flow | $-33.8K | $-41.2K | $9M | · | · | $4M | $4M | $0 | $5M | $0 | $0 | $15 | $14M | $5.0K | $4M | $0 | |
| Free Cash Flow | · | · | · | · | · | · | · | · | $-3M | · | · | · | · | · | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -4457.5% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -4045.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -4457.5% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -37.1% | · | -19.5% | -27.7% | -22.0% | · | -21.4% | · | -16.3% | · | -25.2% | -14.3% | 47.2% | · | -2.9% | -4.7% | |
| ROE | -47.8% | · | -27.9% | -98.4% | -33.2% | · | -39.0% | · | -27.5% | · | -47.6% | -30.3% | 124.2% | · | 53.5% | 47.7% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.2 | · | 6.9 | 3.4 | 3.6 | · | 1.6 | · | 2.8 | · | 2.6 | 3.5 | 2.2 | · | 1.5 | 0.7 | |
| Quick Ratio | 6.1 | · | 6.9 | 3.3 | 3.4 | · | 1.6 | · | 2.8 | · | 2.6 | 3.4 | 2.2 | · | 1.4 | 0.6 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.58 | · | $3.07 | $2.49 | $2.99 | · | $0.62 | · | $5.80 | · | $1.40 | $1.81 | $2.12 | · | $0.09 | $-0.12 | |
| Revenue / Share | $0.02 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | · | · | · | $-2.88 | · | · | · | $-2.60 | · | · | · | $-0.50 | · | · | · | |
| Cash / Share | $2.94 | · | $3.54 | $3.37 | $3.84 | · | $1.52 | · | $8.91 | · | $2.22 | $2.49 | $3.74 | · | $0.26 | $0.23 | |
| EPS (TTM) | $-18.41 | · | $-781.52 | $-819.90 | $-1038.13 | · | $-355.53 | $-325.32 | $-84.88 | · | $-105.93 | $-97.90 | $-96.23 | · | $-60.64 | $-59.21 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-11M | · | $-8M | $-8M | $-14M | · | $-16M | $-16M | $-9M | · | $875.1K | $2M | $2M | · | $-13M | $-15M | |
| Market Cap | $35.6K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -202307.7% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utile netto | $-9M | $-15M | $-120.3K | $-11M | $-12M |
| EPS Diluito | $-23.95 | $-1052.16 | $-8.44 | $-149.20 | $-42.50 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 5.4 | 3.4 | · | 1.2 | 0.0 |
| Quick Ratio | 5.4 | 3.4 | · | 1.2 | 0.0 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | · | $-18M | · | · | · |
Proprietari istituzionali (13F) 14 filer · $13K totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
14
Valore detenuto
$13K
Nuove posizioni
2
Posizioni chiuse
0
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 2 (+1 vs trimestre precedente) | 0 (-1 vs trimestre precedente) | 1 (-2 vs trimestre precedente) | 6 (+6 vs trimestre precedente) | +47K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| CLEAR STREET LLC | $2.971 | 247.584 | 22,92% | Azioni |
| Linden Advisors LP | $2.398 | 337.752 | 18,50% | Azioni |
| Clear Street Group Inc. | $1.951 | 246.934 | 15,05% | Azioni |
| Pine Valley Investments Ltd Liability Co | $1.872 | 236.857 | 14,44% | Azioni |
| T3 Companies, LLC | $1.565 | 198.090 | 12,07% | Azioni |
| TORONTO DOMINION BANK | $792 | 99.050 | 6,11% | Azioni |
| WOLVERINE ASSET MANAGEMENT LLC | $433 | 54.752 | 3,34% | Azioni |
| JANE STREET GROUP, LLC | $395 | 50.000 | 3,05% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $262 | 42.266 | 2,02% | Azioni |
| Soltis Investment Advisors LLC | $178 | 22.500 | 1,37% | Azioni |
| CITADEL ADVISORS LLC | $116 | 18.716 | 0,89% | Azioni |
| UBS Group AG | $28 | 3.532 | 0,22% | Azioni |
| Quaker Wealth Management, LLC | $4 | 387 | 0,03% | Azioni |
| Virtu Financial LLC | $0 | 50.463 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| George F Tidmarsh | 15 Febbraio 2022 | · | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 5 insider · 2 dirigenti · 4 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| James Rolke | Chief Executive Officer | 17 Agosto 2026 A | 422.814 | 0 | 0 | $0 |
| Chester Stanley Zygmont III | Chief Financial Officer | 17 Agosto 2026 G | 300.136 | 0 | 0 | $0 |
| Jennifer Carver | Direttore | 17 Agosto 2026 A | 44.769 | 0 | 0 | $0 |
| Lakhmir S Chawla | Direttore | 17 Agosto 2026 A | 44.169 | 0 | 0 | $0 |
| Jess Roper | Direttore | 17 Agosto 2026 A | 44.839 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 6, 2026